iMD Companies, Inc. Subsidiary Riize, LLC to Expand Product Line With Contracted Telemedicine Doctors
iMD Companies, Inc. (OTC: ICBU) has completed the acquisition of Riize, , a telemedicine company specializing in personal healthcare. Riize plans to expand its product line in September 2024 to include TRT, HRT, and Hair Growth solutions, targeting consumer personal care verticals with projected growth rates of 8% or more. The company also aims to launch its telemedicine platform in Canada between late September and early October 2024.
Riize has shown significant growth, with a 6x increase in sales order volume and a 3x growth in online subscribers for its sexual health products from September 2023 to March 2024. The acquisition is expected to create new strategic opportunities and strengthen both companies' positions in the telemedicine and personal healthcare markets.
iMD Companies, Inc. (OTC: ICBU) ha completato l'acquisizione di Riize, una compagnia di telemedicina specializzata nella cura personale della salute. Riize prevede di ampliare la propria linea di prodotti a settembre 2024 per includere soluzioni di TRT, HRT e crescita dei capelli, mirando a verticali di cura personale dei consumatori con tassi di crescita previsti dell'8% o più. L'azienda punta anche a lanciare la sua piattaforma di telemedicina in Canada tra la fine di settembre e l'inizio di ottobre 2024.
Riize ha mostrato una significativa crescita, con un incremento di 6 volte nel volume degli ordini di vendita e una crescita di 3 volte degli abbonati online per i suoi prodotti per la salute sessuale da settembre 2023 a marzo 2024. Si prevede che l'acquisizione crei nuove opportunità strategiche e rafforzi le posizioni di entrambe le aziende nei mercati della telemedicina e della salute personale.
iMD Companies, Inc. (OTC: ICBU) ha completado la adquisición de Riize, una empresa de telemedicina especializada en el cuidado personal de la salud. Riize planea ampliar su línea de productos en septiembre de 2024 para incluir soluciones de TRT, HRT y crecimiento del cabello, enfocándose en verticales de cuidado personal para consumidores con tasas de crecimiento proyectadas del 8% o más. La compañía también busca lanzar su plataforma de telemedicina en Canadá entre finales de septiembre y principios de octubre de 2024.
Riize ha mostrado un crecimiento significativo, con un aumento de 6 veces en el volumen de órdenes de venta y un crecimiento de 3 veces en suscriptores en línea para sus productos de salud sexual desde septiembre de 2023 hasta marzo de 2024. Se espera que la adquisición genere nuevas oportunidades estratégicas y fortalezca la posición de ambas empresas en los mercados de telemedicina y cuidado personal de la salud.
iMD Companies, Inc. (OTC: ICBU)는 개인 건강 관리에 특화된 원격 진료 회사인 Riize의 인수를 완료했습니다. Riize는 2024년 9월에 TRT, HRT 및 모발 성장 솔루션을 포함하도록 제품 라인을 확장할 계획이며, 소비자 개인 관리 분야에서 8% 이상의 성장률을 목표로 하고 있습니다. 이 회사는 또한 2024년 9월 하순부터 10월 초 사이에 캐나다에서 원격 진료 플랫폼을 출시할 계획입니다.
Riize는 2023년 9월부터 2024년 3월까지 성 건강 제품의 판매 주문량이 6배 증가하고 온라인 구독자가 3배 성장하는 등 상당한 성장을 보여주었습니다. 이번 인수는 새로운 전략적 기회를 창출하고 두 회사의 원격 진료 및 개인 건강 관리 시장에서의 위치를 강화할 것으로 예상됩니다.
iMD Companies, Inc. (OTC: ICBU) a finalisé l'acquisition de Riize, une entreprise de télémédecine spécialisée dans la santé personnelle. Riize prévoit d'élargir sa gamme de produits en septembre 2024 pour inclure des solutions de TRT, HRT et de croissance capillaire, en visant des segments de soins personnels aux consommateurs avec des taux de croissance projetés de 8 % ou plus. L'entreprise vise également à lancer sa plateforme de télémédecine au Canada entre la fin septembre et début octobre 2024.
Riize a montré une croissance significative, avec une augmentation de 6 fois du volume des commandes de vente et une croissance de 3 fois du nombre d'abonnés en ligne pour ses produits de santé sexuelle de septembre 2023 à mars 2024. On s'attend à ce que cette acquisition crée de nouvelles opportunités stratégiques et renforce les positions des deux entreprises sur les marchés de la télémédecine et des soins personnels.
iMD Companies, Inc. (OTC: ICBU) hat die Übernahme von Riize abgeschlossen, einem Telemedizinunternehmen, das auf persönliche Gesundheitsversorgung spezialisiert ist. Riize plant, seine Produktlinie im September 2024 zu erweitern und Lösungen für TRT, HRT und Haarwachstum anzubieten, wobei angestrebt wird, die Wachstumsraten im Bereich der persönlichen Verbraucherpflege von 8% oder mehr zu erreichen. Das Unternehmen beabsichtigt außerdem, seine Telemedizin-Plattform in Kanada zwischen Ende September und Anfang Oktober 2024 zu starten.
Riize hat ein erhebliches Wachstum gezeigt, mit einem 6-fachen Anstieg des Verkaufsauftragsvolumens und einem 3-fachen Wachstum der Online-Abonnenten für seine Produkte im Bereich sexuelle Gesundheit von September 2023 bis März 2024. Die Übernahme wird voraussichtlich neue strategische Möglichkeiten schaffen und die Position beider Unternehmen auf den Märkten für Telemedizin und persönliche Gesundheitsversorgung stärken.
- Acquisition of Riize, completed, expanding iMD Companies' presence in telemedicine
- Riize experienced 6x growth in sales order volume and 3x growth in online subscribers over 6 months
- Planned expansion of product line to include TRT, HRT, and Hair Growth solutions
- Upcoming launch of telemedicine platform in Canada, incorporating pharmaceutical and medical practitioner solutions
- Targeting consumer personal care verticals with projected growth rates of 8% or more
- None.
New Products Include High Demand Hair Loss, Weight Loss, and Woman's Libido Products
RANCHO CORDOVA, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) has completed the acquisition of Riize, LLC (Riize). As a dynamic and growing Telemedicine company, Riize will soon be expanding its products and markets, bringing additional value and growth opportunities to both companies.
Riize has quickly established itself as an innovative online provider to the men's and women's personal healthcare market. In less than twelve months, from September 2023 through March 2024, Riize saw dynamic growth of 6x in sales order volume and 3x in its online subscriber base for its sexual health product lines.
Riize anticipates adding products for TRT (Testosterone Replacement Therapy), HRT (Hormone Replacement Therapy) and Hair Growth beginning sometime mid-September 2024. These products will target consumer personal care verticals with projected growth rates of
In addition to an expanded product line, Riize will soon launch its telemedicine platform in Canada, incorporating both pharmaceutical and medical practitioner solutions for all products, including sexual wellness. This expansion is anticipated to take place between the end of September and early October 2024.
Reilly Schueler, CEO of Riize Health, states, "Having proven the scalability of our business model and telemedicine platform with innovative sexual health products, joining with IMD brings a whole new set of strategic opportunities. As a wholly-owned subsidiary we look forward to increasing our market reach and product lines."
The combined expertise and talents of both Riize Health and IMD Companies will help create a stronger position in the telemedicine and personal health care verticals going forward.
Rick Wilson, President and CEO of iMD Companies, Inc., states, “We’re happy to announce the finalization of the acquisition and are in full mode to grow this amazing subsidiary Riize. Watch for news on future product line expansion and revenue projections.”
Follow Riize Social Media
Website @ https://www.riizehealth.com
Facebook @ https://www.facebook.com/riizehealth
Instagram @ https://www.instagram.com/riizehealth/
Tiktok @ https://www.tiktok.com/@riize_up_llc
Blogs @ https://riizehealth.com/pages/recent-blog-post
About Riize, LLC
Riize is revolutionizing the healthcare industry as a leading telemedicine/pharmacy services provider. Our specialized focus on men’s and women’s sexual health and weight loss sets us apart from the competition due to our revolutionary delivery system. We are proud to offer a convenient and innovative online healthcare service that connects individuals with licensed healthcare providers. At Riize, we understand the importance of personalized care. That’s why we provide a platform where patients can easily consult with healthcare professionals remotely. Through video or phone calls, individuals can discuss their symptoms, receive accurate diagnoses, and obtain personalized treatment plans that address their specific needs. We believe in breaking down barriers to healthcare access. With Riize, patients no longer have to endure long wait times or travel to a physical clinic. Our user-friendly platform ensures that quality healthcare is just a few clicks away. Join us in shaping the future of healthcare. Experience the convenience and expertise that Riize offers. Your health and well-being are our priorities.
Follow iMD Companies, Inc. Social Media
Twitter @ https://twitter.com/imd_inc
Instagram @ https://www.instagram.com/imdcompaniesinc/
About iMD Companies, Inc.
iMD Companies. Inc. (OTC:ICBU) is a Florida Corporation. The company has been re-positioned to be a holding company for acquisitions and technology development in the health care markets. iMD's goal is to combine the expertise of our team members to create a cohesive force, which will carry the company forward in the marketplace.
Safe Harbor Statement
Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.
Contact:
iMD Companies, Inc.
info@imdcompaniesinc.com
FAQ
What new products is Riize, planning to introduce in September 2024?
How much growth did Riize, experience in sales order volume from September 2023 to March 2024?
When does Riize, plan to launch its telemedicine platform in Canada?
What is the stock symbol for iMD Companies, Inc.?
